Bielekova, B., Richert, N., Howard, T., Blevins, G., Markovic-Plese, S., McCartin, J., . . . Martin, R. (2004). Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β. National Academy of Sciences.
Stile di citazione ChicagoBielekova, Bibiana, et al. Humanized Anti-CD25 (daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β. National Academy of Sciences, 2004.
Citazione MLABielekova, Bibiana, et al. Humanized Anti-CD25 (daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β. National Academy of Sciences, 2004.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.